| Print
AstraZeneca PLC (AZN)
American Depository ReceiptOpen
$69.16
Previous close
$68.51
Trade high
$69.7126
Volume
3,432,145
Year high
$87.675
Year low
$61.24
Dividend yield
2.26%
Market capitalisation
$215.63 bn
P/E ratio
30.45
ISIN
US0463531089
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 09/08/2024 | 21/02/2025 |
| Ex-dividend date | 09/08/2024 | 21/02/2025 |
| Payment date | 09/09/2024 | 24/03/2025 |
| Amount | $0.50 | $1.05 |
Company profile
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.